BiotechTube
Home/Sol-Gel Technologies/Lior Finkelstein
LF

Lior Finkelstein

Vice President, Operations

Sol-Gel Technologies

Therapeutic Areas

DermatologyAcneRosaceaPsoriasis

Sol-Gel Technologies Pipeline

DrugIndicationPhase
TWYNEO® (tretinoin/BPO)Acne vulgarisCommercial
EPSOLAY® (encapsulated BPO)Papulopustular RosaceaCommercial
SGT-210OnychomycosisPhase 2
SGT-310Facial Angiofibromas in TSCPhase 2
SGT-610Prurigo NodularisPhase 2
SGT-510Acne VulgarisPhase 2
SGT-710Seborrheic DermatitisPhase 2

Leadership Team at Sol-Gel Technologies

AS
Alon Seri-Levy
Chief Executive Officer & Director
GM
Gilad Mamlok
Chief Financial Officer
MD
Marc D. Brown
Chief Scientific Officer
DT
David T. Tousley
Chief Commercial Officer
View full Sol-Gel Technologies profile